Loading...

Kiichiro Tomoda

TitleStaff Research Investigator
SchoolUCSF School of Medicine
DepartmentGladstone Institutes
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Hayashi Y, Hsiao EC, Sami S, Lancero M, Schlieve CR, Nguyen T, Yano K, Nagahashi A, Ikeya M, Matsumoto Y, Nishimura K, Fukuda A, Hisatake K, Tomoda K, Asaka I, Toguchida J, Conklin BR, Yamanaka S. BMP-SMAD-ID promotes reprogramming to pluripotency by inhibiting p16/INK4A-dependent senescence. Proc Natl Acad Sci U S A. 2016 Nov 15; 113(46):13057-13062. PMID: 27794120.
      View in: PubMed
    2. Kime C, Sakaki-Yumoto M, Goodrich L, Hayashi Y, Sami S, Derynck R, Asahi M, Panning B, Yamanaka S, Tomoda K. Autotaxin-mediated lipid signaling intersects with LIF and BMP signaling to promote the naive pluripotency transcription factor program. Proc Natl Acad Sci U S A. 2016 Nov 1; 113(44):12478-12483. PMID: 27738243.
      View in: PubMed
    3. Kime C, Rand TA, Ivey KN, Srivastava D, Yamanaka S, Tomoda K. Practical Integration-Free Episomal Methods for Generating Human Induced Pluripotent Stem Cells. Curr Protoc Hum Genet. 2015; 87:21.2.1-21.2.21. PMID: 26439714.
      View in: PubMed
    4. Hayashi Y, Caboni L, Das D, Yumoto F, Clayton T, Deller MC, Nguyen P, Farr CL, Chiu HJ, Miller MD, Elsliger MA, Deacon AM, Godzik A, Lesley SA, Tomoda K, Conklin BR, Wilson IA, Yamanaka S, Fletterick RJ. Structure-based discovery of NANOG variant with enhanced properties to promote self-renewal and reprogramming of pluripotent stem cells. Proc Natl Acad Sci U S A. 2015 Apr 14; 112(15):4666-71. PMID: 25825768; PMCID: PMC4403148.
    5. Spencer CI, Baba S, Nakamura K, Hua EA, Sears MA, Fu CC, Zhang J, Balijepalli S, Tomoda K, Hayashi Y, Lizarraga P, Wojciak J, Scheinman MM, Aalto-Setälä K, Makielski JC, January CT, Healy KE, Kamp TJ, Yamanaka S, Conklin BR. Calcium transients closely reflect prolonged action potentials in iPSC models of inherited cardiac arrhythmia. Stem Cell Reports. 2014 Aug 12; 3(2):269-81. PMID: 25254341; PMCID: PMC4175159.
    6. Tomoda K, Takahashi K, Leung K, Okada A, Narita M, Yamada NA, Eilertson KE, Tsang P, Baba S, White MP, Sami S, Srivastava D, Conklin BR, Panning B, Yamanaka S. Derivation conditions impact X-inactivation status in female human induced pluripotent stem cells. Cell Stem Cell. 2012 Jul 6; 11(1):91-9. PMID: 22770243; PMCID: PMC3396435.
    7. Nakamura K, Salomonis N, Tomoda K, Yamanaka S, Conklin BR. G(i)-coupled GPCR signaling controls the formation and organization of human pluripotent colonies. PLoS One. 2009; 4(11):e7780. PMID: 19936228; PMCID: PMC2777408.
    8. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007 Nov 30; 131(5):861-72. PMID: 18035408.
      View in: PubMed
    9. Nakamura T, Higashi S, Tomoda K, Tsukano M, Baba S. Efficacy of etanercept in patients with AA amyloidosis secondary to rheumatoid arthritis. Clin Exp Rheumatol. 2007 Jul-Aug; 25(4):518-22. PMID: 17888205.
      View in: PubMed
    10. Kato JY, Nakamae I, Tomoda K, Fukumoto A, Yoneda-Kato N. Preparation and characterization of monoclonal antibodies against mouse Jab1/CSN5 protein. Hybridoma (Larchmt). 2006 Dec; 25(6):342-8. PMID: 17203996.
      View in: PubMed
    11. Fukumoto A, Tomoda K, Yoneda-Kato N, Nakajima Y, Kato JY. Depletion of Jab1 inhibits proliferation of pancreatic cancer cell lines. FEBS Lett. 2006 Oct 30; 580(25):5836-44. PMID: 17027978.
      View in: PubMed
    12. Ando T, Ishiguro H, Kimura M, Mitsui A, Kurehara H, Sugito N, Tomoda K, Mori R, Takashima N, Ogawa R, Fujii Y, Kuwabara Y. Decreased expression of NDRG1 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma. Dis Esophagus. 2006; 19(6):454-8. PMID: 17069588.
      View in: PubMed
    13. Nakamura T, Higashi S, Tomoda K, Tsukano M, Baba S, Shono M. Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis. Rheumatology (Oxford). 2006 Jan; 45(1):43-9. PMID: 16219644.
      View in: PubMed
    14. Yoneda-Kato N, Tomoda K, Umehara M, Arata Y, Kato JY. Myeloid leukemia factor 1 regulates p53 by suppressing COP1 via COP9 signalosome subunit 3. EMBO J. 2005 May 4; 24(9):1739-49. PMID: 15861129; PMCID: PMC1142586.
    15. Fukumoto A, Tomoda K, Kubota M, Kato JY, Yoneda-Kato N. Small Jab1-containing subcomplex is regulated in an anchorage- and cell cycle-dependent manner, which is abrogated by ras transformation. FEBS Lett. 2005 Feb 14; 579(5):1047-54. PMID: 15710389.
      View in: PubMed
    16. Tomoda K, Kato JY, Tatsumi E, Takahashi T, Matsuo Y, Yoneda-Kato N. The Jab1/COP9 signalosome subcomplex is a downstream mediator of Bcr-Abl kinase activity and facilitates cell-cycle progression. Blood. 2005 Jan 15; 105(2):775-83. PMID: 15353483.
      View in: PubMed
    17. Tomoda K, Yoneda-Kato N, Fukumoto A, Yamanaka S, Kato JY. Multiple functions of Jab1 are required for early embryonic development and growth potential in mice. J Biol Chem. 2004 Oct 8; 279(41):43013-8. PMID: 15299027.
      View in: PubMed
    18. Fukumoto A, Ikeda N, Sho M, Tomoda K, Kanehiro H, Hisanaga M, Tsurui Y, Tsutsumi M, Kato JY, Nakajima Y. Prognostic significance of localized p27Kip1 and potential role of Jab1/CSN5 in pancreatic cancer. Oncol Rep. 2004 Feb; 11(2):277-84. PMID: 14719054.
      View in: PubMed
    19. Nakamura T, Yamamura Y, Tomoda K, Tsukano M, Baba S. Massive hematuria due to bladder amyloidosis in patients with rheumatoid arthritis: three case reports. Clin Exp Rheumatol. 2003 Sep-Oct; 21(5):673-4. PMID: 14611124.
      View in: PubMed
    20. Tomoda K, Kubota Y, Arata Y, Mori S, Maeda M, Tanaka T, Yoshida M, Yoneda-Kato N, Kato JY. The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex. J Biol Chem. 2002 Jan 18; 277(3):2302-10. PMID: 11704659.
      View in: PubMed
    21. Sugiyama Y, Tomoda K, Tanaka T, Arata Y, Yoneda-Kato N, Kato J. Direct binding of the signal-transducing adaptor Grb2 facilitates down-regulation of the cyclin-dependent kinase inhibitor p27Kip1. J Biol Chem. 2001 Apr 13; 276(15):12084-90. PMID: 11278754.
      View in: PubMed
    22. Nakamura T, Baba S, Yamamura Y, Tsuruta T, Matsubara S, Tomoda K, Tsukano M. Combined treatment with cyclophosphamide and prednisolone is effective for secondary amyloidosis with SAA1?/? genotype in a patient with rheumatoid arthritis. Mod Rheumatol. 2000 Sep; 10(3):160-4. PMID: 24383594.
      View in: PubMed
    23. Tomoda K, Kubota Y, Kato J. Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Nature. 1999 Mar 11; 398(6723):160-5. PMID: 10086358.
      View in: PubMed
    24. Nishimura M, Ohtake S, Sawa Y, Imagawa H, Yamakawa T, Nakamura T, Maeda M, Tomoda K, Nakamura H, Matsuda H. Endovascular stent graft placement for patients with aortic aneurysm and end-organ dysfunction. ASAIO J. 1998 Sep-Oct; 44(5):M511-5. PMID: 9804483.
      View in: PubMed
    25. Kim T, Murakami T, Takahashi S, Okada A, Hori M, Nobuhiro M, Tomoda K, Narumi Y, Oi H, Nakamura H. [Gd-DTPA enhanced multi-shot echo-planar MRI: improvement of contrast between metastatic liver cancer and liver parenchyma]. Nihon Igaku Hoshasen Gakkai Zasshi. 1998 Apr; 58(5):235-7. PMID: 9617159.
      View in: PubMed
    26. Takahashi S, Kim T, Murakami T, Hori M, Okada A, Nakata S, Tsuda K, Narumi Y, Tomoda K, Oi H, Nakamura H. [Three-dimensional gadolinium-enhanced dynamic MRI of whole liver using spectrally selected enhanced fast gradient recall sequence]. Nihon Igaku Hoshasen Gakkai Zasshi. 1998 Feb; 58(3):99-101. PMID: 9558853.
      View in: PubMed
    27. Tomoda K, Kato J. [Cdk inhibiting proteins]. Gan To Kagaku Ryoho. 1997 Sep; 24(11):1407-13. PMID: 9309133.
      View in: PubMed
    28. Murakami T, Tomoda K, Sakamoto T, Kim T, Tsuda K, Takahashi S, Okada A, Sugiura T, Narumi Y, Nakamura H. [Trial of a detachable Y-shaped tube with two valves for serial examinations of CT arterial portography and CT hepatic arteriography]. Nihon Igaku Hoshasen Gakkai Zasshi. 1997 Jun; 57(7):430-2. PMID: 9232994.
      View in: PubMed
    29. Araki Y, Tomoda K, Nishiyama K, Ikeda H, Chatani M, Mori S. Quantitative evaluation of radiotherapy treatment planning using CT image. Strahlenther Onkol. 1987 Oct; 163(10):659-63. PMID: 3672314.
      View in: PubMed
    30. Araki Y, Tomoda K, Mori S, Mitomo M. [A long-taper catheter device]. Rinsho Hoshasen. 1987 May; 32(5):661-3. PMID: 3039209.
      View in: PubMed
    31. Hori S, Narumi Y, Marukawa T, Tomoda K, Katayama K, Tanaka T, Tokunaga K, Yoshioka H, Kuroda C. [A new intravenous liposoluble contrast material for computed tomography of the liver. Experimental study of iodized emulsion in rabbits]. Nihon Igaku Hoshasen Gakkai Zasshi. 1984 Jul 25; 44(7):988-91. PMID: 6096804.
      View in: PubMed
    32. Takahashi K, Katami K, Nakamura K, Tomoda K, Fujiwara K. IgG type myeloma in a dog. Nihon Juigaku Zasshi. 1980 Apr; 42(2):271-5. PMID: 7382241.
      View in: PubMed
    Kiichiro's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP